RECRUITINGINTERVENTIONAL

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Increasing Physical Activity Via Provider Prescription and Engagement: Efficacy of ExerciseRx for Adults With Multiple Sclerosis (MS)

About This Trial

This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).

Who May Be Eligible (Plain English)

Who May Qualify: - Provider-confirmed diagnosis of MS using revised 2017 McDonald criteria - \> 18+ years of age - Patient determined disease steps (PDDS) score \< 3, indicating the potential for some gait disability although typically ambulates without an assistive device - Insufficiently active, defined as \< 150 minutes of physical activity per week, assessed using the PAVS in the EHR in clinics as part of the routine patient intake process - Use of an iPhone with software version iOS13+ or an Android phone 4.1+ - Agree to install and use the ExerciseRx app for the entire study period and keep their phone on them during the daytime (e.g., pocket, bags, hands) Who Should NOT Join This Trial: - Recent (past 4 weeks) or planned surgery during the study period which may impact engaging in step counts - MS relapse within the last 30 days - Plans to travel internationally during the study period, which could interfere with server uploads of mobile phone data - Those at a higher risk of falling or injury from falls or unable to safely exercise due to other medical conditions (e.g. heart conditions, diabetes or conditions made worse by walking or physical activity) Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Provider-confirmed diagnosis of MS using revised 2017 McDonald criteria * \> 18+ years of age * Patient determined disease steps (PDDS) score \< 3, indicating the potential for some gait disability although typically ambulates without an assistive device * Insufficiently active, defined as \< 150 minutes of physical activity per week, assessed using the PAVS in the EHR in clinics as part of the routine patient intake process * Use of an iPhone with software version iOS13+ or an Android phone 4.1+ * Agree to install and use the ExerciseRx app for the entire study period and keep their phone on them during the daytime (e.g., pocket, bags, hands) Exclusion Criteria: * Recent (past 4 weeks) or planned surgery during the study period which may impact engaging in step counts * MS relapse within the last 30 days * Plans to travel internationally during the study period, which could interfere with server uploads of mobile phone data * Those at a higher risk of falling or injury from falls or unable to safely exercise due to other medical conditions (e.g. heart conditions, diabetes or conditions made worse by walking or physical activity)

Treatments Being Tested

OTHER

ExerciseRx intervention

ExerciseRx is a cloud-based, HIPPA-compliant free software platform created for healthcare providers to prescribe and monitor physical activity as part of routine care. ExerciseRx translates clinically relevant activity data collected by the patient's existing personal smart devices (Android or iOS phone) into actionable metrics on a dashboard within the Epic electronic health record. Providers then use the platform to prescribe physical activity tailored to patients' ability levels and preferences. The platform incorporates behavior change strategies, including motivational feedback and nudges. It also facilitates a feedback loop with the provider, fostering caring patient-provider connections around activity promotion and behavior change. ExerciseRx leverages patients' personal smartphone capabilities to track, quantify, and tailor personalized physical activity solutions, which makes it more readily scalable as a solution across diverse patient populations.

Locations (1)

UW Medicine

Seattle, Washington, United States